Unique ID issued by UMIN | UMIN000022148 |
---|---|
Receipt number | R000025518 |
Scientific Title | Transcranial magnetic stimulation (TMS) in the treatment of refractory bipolar depression: a preliminary study |
Date of disclosure of the study information | 2016/05/09 |
Last modified on | 2018/10/03 13:48:05 |
Transcranial magnetic stimulation (TMS) in the treatment of refractory bipolar depression: a preliminary study
Transcranial magnetic stimulation (TMS) in the treatment of refractory bipolar depression
Transcranial magnetic stimulation (TMS) in the treatment of refractory bipolar depression: a preliminary study
Transcranial magnetic stimulation (TMS) in the treatment of refractory bipolar depression
Japan |
Bipolar depression
Psychiatry |
Others
NO
To examine the efficacy and tolerability of low-frequency right prefrontal transcranial magnetic stimulation in treatment-resistant bipolar depression and to identify a biological marker about its treatment response
Safety,Efficacy
Changes in the total score of Hamilton's Rating Scale for Depression (HAMD 17 items) at week 4
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
Low-frequency right prefrontal transcranial magnetic stimulation for 4 weeks
20 | years-old | <= |
75 | years-old | >= |
Male and Female
1. DSM-5 diagnosis of bipolar disorder, major depressive disorder
2. HAMD 17 score >= 18
3. Current episode duration < 3 y
4. Patient does not respond to the medications described below for more than 8 weeks.
i. Lithium, 0.8mmol/L
ii. Quetiapine, 300mg/day
iii. Olanzapine, 5-20mg/day
iv. Lamotrigine, 200mg/day
1. Rapid cycler type
2. Patient has a history of psychotic episode, OCD, PTSD, and eating disorder.
3. Patient had a previous treatment with ECT, TMS, VNS, DBS, and tDCS within 6 months.
4. Patient did not respond to ECT and TMS previously.
5. Pregnancy
6. Patient has a history of epilepsy and convulsion. Personal or close family history of seizure disorder
7. Neurologic disorder, organic brain disease
8. Substance or alcohol dependence
9. Ferromagnetic material in body or close to head
10. Severe metabolic disease, endocrine disease
11. Active suicide idea
12. Taking medications known to lower seizure threshold
40
1st name | |
Middle name | |
Last name | Shinsuke Kito |
National Center Hospital, National Center of Neurology and Psychiatry
Department of Psychiatry and Advanced Medical Technology
4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8551, Japan
042-341-2711
kito@ncnp.go.jp
1st name | |
Middle name | |
Last name | Shinsuke Kito |
National Center of Neurology and Psychiatry
Department of Psychiatry and Advanced Medical Technology
4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8551, Japan
042-341-2711
kito@ncnp.go.jp
National Center Hospital, National Center of Neurology and Psychiatry
1. Fiduciary funding by Inter Reha Co.,Ltd
2. Self funding
Other
NO
2016 | Year | 05 | Month | 09 | Day |
Published
Completed
2016 | Year | 04 | Month | 20 | Day |
2016 | Year | 05 | Month | 09 | Day |
2016 | Year | 04 | Month | 30 | Day |
2018 | Year | 10 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025518